References

  1. National Institute for Health and Care Excellence (NICE). Breast cancer: Quality Standard QS12. NICE. 2016. Available at: https://www.nice.org.uk/guidance/qs12. Accessed May 2025.
  2. Cancer Research UK. Why is early diagnosis important? Cancer Research UK. 2023. Available at: https://www.cancerresearchuk.org/about-cancer/spot-cancer-early/why-is-early-diagnosis-important. Accessed May 2025.
  3. World Cancer Research Fund International. Breast cancer statistics. London, UK: WCRF International. 2024. Available at: https://www.wcrf.org/preventing-cancer/cancer-statistics/breast-cancer-statistics/. Accessed May 2025.
  4. World Health Organization. Global cancer burden growing amidst mounting need for services. Geneva, Switzerland: WHO. 2024. Available at: https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services. Accessed May 2025.
  5. Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–263.
  6. Kim J, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31(4):1154–1162.
  7. Wang L. Early Diagnosis of Breast Cancer. Sensors. 2017;17:1572.
  8. Wang X, et al. Avoidable and unavoidable repeat breast core needle biopsies. Arch Breast Cancer. 2022;9:32–39.
  9. Shaaban AM, et al. Management of B3 Lesions-Practical issues. Curr Breast Cancer Rep. 2019;11:83–88.
  10. Zhang Y, et al. The comparison of efficacy and safety evaluation of vacuum-assisted Elite 10-G system and the traditional BARD 14-G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial. Int J Surg. 2023;109(5):1180–1187.
  11. O'Flynn EA, et al. Image-guided breast biopsy: state-of-the-art. Clin Radiol. 2010;65(4):259–270.
  12. Philpotts LE, et al. Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol.1999;172(3):683–687.
  13. Szynglarewicz B, et al. Pain experienced by patients during minimal-invasive ultrasound-guided breast biopsy: vacuum-assisted vs core-needle procedure. Eur J Surg Oncol. 2011;37(5):398–403.
  14. van de Voort EMF, et al. Implementation of vacuum-assisted excision as a management option for benign and high-risk breast lesions. Br J Radiol. 2023;96(1147);20220776.
  15. Salazar JP, et al. Percutaneous ultrasound-guided vacuum-assisted excision of benign breast lesions: A learning curve to assess outcomes. Br J Radiol. 2019; 921(1094);20180626.
  16. Gil MLBV, et al. Vacuum-assisted excision: A safe minimally invasive option for benign phyllodes tumor diagnosis and treatment-a systematic review and meta-analysis. Front Oncol. 2024;14:1394116.
  17. Yoo H-S, et al. Efficacy and safety of vacuum-assisted excision for benign breast mass lesion: A meta-analysis. Medicina. 2021;57:1260.
  18. Perretta T, et al. Evaluation of ultrasound-guided 8-gauge vacuum-assisted excision system for the removal of US-detectable breast lesions. Anticancer Res. 2020;40:1719-1729.
  19. Ko EY, et al. Factors affecting the efficacy of ultrasound-guided vacuum-assisted percutaneous excision for removal of benign breast lesions. J Ultrasound Med. 2008; 27:65-73.
  20. Sharma N, et al. impact of vacuum-assisted excision in the management of indeterminate B3 lesions in the NHS Breast Screening Programme in England. Clin Radiol. 2021;470.e23-470.e29.
  21. Martin EA, et al. Current status of biopsy markers for the breast in clinical settings. Expert Rev Med Devices. 2022;19(12):965-975.
  22. Shah AD, et al. Breast tissue markers: Why? What's out there? How do I choose?. Clin Imaging. 2018;52:123-136.
  23. Alshafeiy TI, et al. Advantages and challenges of Using breast biopsy markers. J Breast Imaging. 2022;4(1):78-95.
  24. Harvey JA. To Place a Breast Biopsy Marker or Not? J Breast Imaging. 2022;4(3):229-230.

Join us and start your journey to diagnostic excellence

Don't miss out! Agree to receive communications and enjoy exclusive access to clinical data, special events, and content curated just for our Women's Health community.